Carcinoma, Renal CellKidney NeoplasmsPyrrolesBenzenesulfonatesIndolesPhenylurea CompoundsNiacinamideNeoplasm MetastasisNephrectomyInterferon-alphaHand-Foot SyndromeAntineoplastic AgentsInterleukin-2Angiogenesis InhibitorsTreatment OutcomePyridinesDisease-Free SurvivalInjections, SubcutaneousImmunotherapyMolecular Targeted TherapyDrug Administration ScheduleProtein Kinase InhibitorsAdenocarcinoma, Clear CellIndazolesPrognosisSurvival AnalysisVon Hippel-Lindau Tumor Suppressor ProteinSirolimusSurvival RateRetrospective StudiesMetastasectomyRecombinant ProteinsAntineoplastic Combined Chemotherapy ProtocolsDrug EvaluationRorschach TestIsotretinoinKaplan-Meier EstimateTumor Markers, BiologicalClinical Trials, Phase III as TopicAntibodies, Monoclonal, HumanizedInfusions, IntravenousClinical Trials as TopicVascular Endothelial Growth Factor ADisease ProgressionNeoplasm StagingLymphocytes, Tumor-InfiltratingBone NeoplasmsAntibodies, MonoclonalThalidomideTomography, X-Ray ComputedCancer VaccinesAdministration, OralTOR Serine-Threonine KinasesTime FactorsClinical Trials, Phase II as TopicThyroid Function TestsReceptors, Vascular Endothelial Growth FactorAdenoma, OxyphilicCarbonic AnhydrasesInterferon Type ILung NeoplasmsFluorouracilGraft vs Tumor EffectImmunohistochemistryOutpatientsHypothyroidismMultivariate AnalysisImidazolesCombined Modality TherapyDose-Response Relationship, DrugImmunotherapy, AdoptiveMaximum Tolerated DoseRandomized Controlled Trials as TopicAntigens, NeoplasmFatigueRemission InductionCell Line, TumorFollow-Up StudiesL-Lactate DehydrogenaseKidneyCytokinesvon Hippel-Lindau DiseaseDrug Resistance, NeoplasmNeovascularization, PathologicRisk AssessmentProportional Hazards ModelsLymphatic MetastasisInjections, IntravenousLeiomyomatosisLiver NeoplasmsPredictive Value of TestsCohort StudiesHemoglobinsFeasibility StudiesFumarate HydrataseDouble-Blind MethodJapanRisk FactorsPilot ProjectsDrug Therapy, Combination
Malignant2
- Malignant tumours, both major and metastatic, infiltrate and destroy the important constructions. (love66.me)
- Differential cytokeratin expression in normal hyperplastic and malignant epithelial cells from human prostate. (tradingsignalsforex.com)
Carcinoma1
- Refractory advanced renal-cell carcinoma. (medscape.com)